- Home
- SANA vs ARDX Comparison
SANA vs ARDX Comparison
Compare SANA & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SANA
- ARDX
- Stock Information
- Founded
- SANA 2018
- ARDX 2007
- Country
- SANA United States
- ARDX United States
- Employees
- SANA N/A
- ARDX N/A
- Industry
- SANA Medicinal Chemicals and Botanical Products
- ARDX Biotechnology: Pharmaceutical Preparations
- Sector
- SANA Health Care
- ARDX Health Care
- Exchange
- SANA Nasdaq
- ARDX Nasdaq
- Market Cap
- SANA 983.4M
- ARDX 882.9M
- IPO Year
- SANA 2021
- ARDX 2014
- Fundamental
- Price
- SANA $3.91
- ARDX $4.33
- Analyst Decision
- SANA Strong Buy
- ARDX Strong Buy
- Analyst Count
- SANA 6
- ARDX 9
- Target Price
- SANA $10.00
- ARDX $10.17
- AVG Volume (30 Days)
- SANA 5.5M
- ARDX 3.9M
- Earning Date
- SANA 08-11-2025
- ARDX 08-04-2025
- Dividend Yield
- SANA N/A
- ARDX N/A
- EPS Growth
- SANA N/A
- ARDX N/A
- EPS
- SANA N/A
- ARDX N/A
- Revenue
- SANA N/A
- ARDX $361,706,000.00
- Revenue This Year
- SANA N/A
- ARDX $10.10
- Revenue Next Year
- SANA N/A
- ARDX $32.38
- P/E Ratio
- SANA N/A
- ARDX N/A
- Revenue Growth
- SANA N/A
- ARDX 127.33
- 52 Week Low
- SANA $1.26
- ARDX $3.21
- 52 Week High
- SANA $7.30
- ARDX $7.18
- Technical
- Relative Strength Index (RSI)
- SANA 47.52
- ARDX 52.98
- Support Level
- SANA $4.72
- ARDX $4.21
- Resistance Level
- SANA $5.33
- ARDX $4.47
- Average True Range (ATR)
- SANA 0.35
- ARDX 0.18
- MACD
- SANA -0.14
- ARDX -0.04
- Stochastic Oscillator
- SANA 3.40
- ARDX 41.46
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.
About ARDX Ardelyx Inc.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.